Skip to main content
Find more clinical trials

Alzheimer's Caregiver Coping: Mental and Physical Health

Start: September 2014
End: June 30, 2019
Enrollment: 200

What Is This Study About?

This study will compare two intervention strategies for reducing emotional and cardiovascular disease risk in Alzheimer's caregivers: Behavioral Activation therapy and Support and Information.

Do I Qualify To Participate in This Study?

Minimum Age: 55 Years

Maximum Age: N/A

Must have:

  • Providing in-home care to a spouse with dementia

Must NOT have:

  • Prohibited medications: warfarin (Coumarin), nitrates, niacin, non-selective beta-blockers, methyldopa (Aldomet), labetalol (Normozide)
  • Glucocorticoid use in the 2 weeks before enrollment
  • Diagnosis of a terminal illness with life expectancy of less than 1 year (caregiver and person with Alzheimer's)
  • Enrollment in another intervention study
  • Receiving psychotherapy to improve well-being or reduce stress
  • Blood pressure of more than 200/120 mm Hg

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.

 
Study Contact
Brent T. Mausbach, PhD
Jean-Loup Bitterlin

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

California
University of California San Diego
La Jolla, CA 92093

Who Sponsors This Study?

Lead: University of California, San Diego

Collaborator Sponsor

  • National Institute on Aging (NIA)

Source: ClinicalTrials.gov ID: NCT02317523